Quantinno Capital Management LP Increases Stock Position in Amedisys, Inc. (NASDAQ:AMED)

Quantinno Capital Management LP increased its holdings in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 48.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 59,911 shares of the health services provider's stock after buying an additional 19,454 shares during the quarter. Quantinno Capital Management LP owned about 0.18% of Amedisys worth $5,439,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Blue Trust Inc. boosted its stake in shares of Amedisys by 55.1% in the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after buying an additional 124 shares during the last quarter. Johnson Financial Group Inc. acquired a new position in Amedisys in the 4th quarter valued at $55,000. Vestcor Inc purchased a new stake in Amedisys during the 4th quarter valued at about $73,000. Venturi Wealth Management LLC boosted its stake in Amedisys by 397.4% during the fourth quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider's stock worth $89,000 after buying an additional 779 shares during the last quarter. Finally, Covestor Ltd increased its position in Amedisys by 48.8% during the fourth quarter. Covestor Ltd now owns 1,037 shares of the health services provider's stock worth $94,000 after purchasing an additional 340 shares during the last quarter. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Amedisys Stock Performance

Shares of NASDAQ:AMED traded down $1.15 on Wednesday, reaching $93.59. The company's stock had a trading volume of 423,980 shares, compared to its average volume of 418,846. Amedisys, Inc. has a 52-week low of $82.15 and a 52-week high of $98.95. The stock has a market capitalization of $3.07 billion, a P/E ratio of 37.14, a PEG ratio of 1.78 and a beta of 0.96. The stock's 50-day moving average is $93.30 and its two-hundred day moving average is $91.62. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share for the quarter, topping analysts' consensus estimates of $1.13 by $0.12. The company had revenue of $594.78 million during the quarter, compared to analysts' expectations of $597.43 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The firm's revenue for the quarter was up 4.1% on a year-over-year basis. During the same period last year, the firm earned $1.03 EPS. As a group, sell-side analysts forecast that Amedisys, Inc. will post 4.4 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on AMED shares. Stephens reiterated an "equal weight" rating and set a $101.00 price target on shares of Amedisys in a research report on Tuesday, March 4th. Royal Bank of Canada reissued an "outperform" rating and issued a $100.00 price objective on shares of Amedisys in a research report on Wednesday, April 16th. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat, Amedisys presently has an average rating of "Hold" and an average target price of $100.75.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.